Grown Rogue International Inc
CNSX:GRIN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Ferrotec An Hui Technology Development Co Ltd
SZSE:301297
|
CN |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (8.5), the stock would be worth CA$-0.16 (134% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -25 | CA$0.47 |
0%
|
| 3-Year Average | 8.5 | CA$-0.16 |
-134%
|
| 5-Year Average | 7.7 | CA$-0.14 |
-131%
|
| Industry Average | 11.3 | CA$-0.21 |
-145%
|
| Country Average | 14.5 | CA$-0.27 |
-158%
|
Forward EV/EBIT
Today’s price vs future ebit
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
G
|
Grown Rogue International Inc
CNSX:GRIN
|
117.3m CAD | -25 | 13.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD | 29.8 | 41.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
544.6B USD | 21.2 | 25.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 13.1 | 19.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
225.8B GBP | 22.7 | 29.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.8B CHF | 15.9 | 20 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
278.5B USD | 11.6 | 15.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 970 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 9.4 | 10.8 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.3B USD | 10.2 | 20 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.6B USD | 8.8 | 17 |
Market Distribution
| Min | 0 |
| 30th Percentile | 10.6 |
| Median | 14.5 |
| 70th Percentile | 20.6 |
| Max | 3 794.4 |
Other Multiples
Grown Rogue International Inc
Glance View
Grown Rogue International, Inc. operates as a seed to experience cannabis brand. The company is headquartered in Toronto, Ontario. The company went IPO on 2016-11-18. The Company’s geographical segments include the United States and Canada. The firm is a vertically integrated cannabis brand that produces and distributes cannabis products. The firm's products include sungrown and indoor flowers, along with nitro-sealed indoor, and sungrown pre-rolls and jars.
